Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2024

Filed with the SEC on Feb 25, 2025 and accepted by EDGAR at Feb 25, 2025, 09:50 ET.

Share

Share this page

Story card, 1080 × 1920

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.

Line itemPeriodValueXBRL concept
Revenue12 months2024-01-01 to 2024-12-31EUR 19.34bnifrs-full:Revenue
Cost of revenue12 months2024-01-01 to 2024-12-31EUR 14.58bnifrs-full:CostOfSales
Operating income12 months2024-01-01 to 2024-12-31EUR 1.39bnifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2024-01-01 to 2024-12-31EUR 316.1mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2024-01-01 to 2024-12-31EUR 537.9mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2024-01-01 to 2024-12-31EUR 1.83ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2024-01-01 to 2024-12-31EUR 1.83ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2024-01-01 to 2024-12-31EUR 2.39bnifrs-full:CashFlowsFromUsedInOperatingActivities
Cash and equivalentsAt period end2024-12-31EUR 1.18bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2024-12-31EUR 7.92bnifrs-full:CurrentAssets
Total assetsAt period end2024-12-31EUR 33.57bnifrs-full:Assets
Current liabilitiesAt period end2024-12-31EUR 5.66bnifrs-full:CurrentLiabilities
Total liabilitiesAt period end2024-12-31EUR 17.80bnifrs-full:Liabilities
Shareholders' equityAt period end2024-12-31EUR 14.58bnifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2024-12-31293,413,449 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001104659-25-016784. Last ingested by Listed: Nov 3, 2026, 10:24 ET. Listed shows no prices and gives no investment advice.